Esther van Dam1, Anne Daly2, Gineke Venema-Liefaard3, Margreet van Rijn3, Terry G J Derks4, Patrick J McKiernan2, M Rebecca Heiner-Fokkema5, Anita MacDonald2, Francjan J van Spronsen4. 1. Department of Dietetics, University of Groningen, University Medical Center Groningen, Beatrix Children's Hospital, Groningen, The Netherlands. e.van.dam@umcg.nl. 2. Birmingham Children's Hospital, Birmingham, UK. 3. Department of Dietetics, University of Groningen, University Medical Center Groningen, Beatrix Children's Hospital, Groningen, The Netherlands. 4. Department of Pediatrics, University of Groningen, University Medical Center Groningen, Beatrix Children's Hospital, Groningen, The Netherlands. 5. Department of Laboratory Medicine, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Abstract
BACKGROUND: Treatment of hereditary tyrosinemia type 1 with nitisinone and phenylalanine and tyrosine restricted diet has largely improved outcome, but the best blood sampling time for assessment of metabolic control is not known. AIM: To study diurnal and day-to-day variation of phenylalanine and tyrosine concentrations in tyrosinemia type 1 patients. METHODS: Eighteen tyrosinemia type 1 patients aged >1 year (median age 7.9 years; range 1.6-20.7) were studied. Capillary blood samples were collected 4 times a day (T1: pre-breakfast, T2: pre-midday meal, T3: before evening meal, and T4: bedtime) for 3 days. Linear mixed-effect models were used to investigate diurnal and day-to-day variation of both phenylalanine and tyrosine. RESULTS: The coefficients of variation of phenylalanine and tyrosine concentrations were the lowest on T1 (13.8% and 14.1%, respectively). Tyrosine concentrations did not significantly differ between the different time points, but phenylalanine concentrations were significantly lower at T2 and T3 compared to T1 (50.1 μmol/L, 29.8 μmol/L, and 37.3 μmol/L, respectively). CONCLUSION: Our results indicated that for prevention of too low phenylalanine and too high tyrosine concentrations, measurement of phenylalanine and tyrosine pre-midday meal would be best, since phenylalanine concentrations are the lowest on that time point. Our results also indicated that whilst blood tyrosine concentrations were stable over 24 h, phenylalanine fluctuated. Day-to-day variation was most stable after an overnight fast for both phenylalanine and tyrosine. Therefore, in tyrosinemia type 1 patients the most reliable time point for measuring phenylalanine and tyrosine concentrations to enable interpretation of metabolic control is pre-breakfast.
BACKGROUND: Treatment of hereditary tyrosinemia type 1 with nitisinone and phenylalanine and tyrosine restricted diet has largely improved outcome, but the best blood sampling time for assessment of metabolic control is not known. AIM: To study diurnal and day-to-day variation of phenylalanine and tyrosine concentrations in tyrosinemia type 1patients. METHODS: Eighteen tyrosinemia type 1patients aged >1 year (median age 7.9 years; range 1.6-20.7) were studied. Capillary blood samples were collected 4 times a day (T1: pre-breakfast, T2: pre-midday meal, T3: before evening meal, and T4: bedtime) for 3 days. Linear mixed-effect models were used to investigate diurnal and day-to-day variation of both phenylalanine and tyrosine. RESULTS: The coefficients of variation of phenylalanine and tyrosine concentrations were the lowest on T1 (13.8% and 14.1%, respectively). Tyrosine concentrations did not significantly differ between the different time points, but phenylalanine concentrations were significantly lower at T2 and T3 compared to T1 (50.1 μmol/L, 29.8 μmol/L, and 37.3 μmol/L, respectively). CONCLUSION: Our results indicated that for prevention of too low phenylalanine and too high tyrosine concentrations, measurement of phenylalanine and tyrosine pre-midday meal would be best, since phenylalanine concentrations are the lowest on that time point. Our results also indicated that whilst blood tyrosine concentrations were stable over 24 h, phenylalanine fluctuated. Day-to-day variation was most stable after an overnight fast for both phenylalanine and tyrosine. Therefore, in tyrosinemia type 1patients the most reliable time point for measuring phenylalanine and tyrosine concentrations to enable interpretation of metabolic control is pre-breakfast.
Authors: Corinne De Laet; Vanessa Terrones Munoz; Jaak Jaeken; Baudouin François; Dietbrandt Carton; Etienne M Sokal; Bernard Dan; Philippe J Goyens Journal: Dev Med Child Neurol Date: 2011-07-11 Impact factor: 5.449
Authors: Danique van Vliet; Esther van Dam; Margreet van Rijn; Terry G J Derks; Gineke Venema-Liefaard; Marrit M Hitzert; Roelineke J Lunsing; M Rebecca Heiner-Fokkema; Francjan J van Spronsen Journal: JIMD Rep Date: 2014-09-26
Authors: F J van Spronsen; T van Dijk; G P Smit; M van Rijn; D J Reijngoud; R Berger; H S Heymans Journal: Am J Clin Nutr Date: 1996-12 Impact factor: 7.045
Authors: F J van Spronsen; M van Rijn; T van Dijk; G P Smit; D J Reijngoud; R Berger; H S Heymans Journal: Pediatrics Date: 1993-10 Impact factor: 7.124
Authors: Kimber van Vliet; Wiggert G van Ginkel; Esther van Dam; Pim de Blaauw; Martijn Koehorst; Hermi A Kingma; Francjan J van Spronsen; M Rebecca Heiner-Fokkema Journal: Orphanet J Rare Dis Date: 2020-04-03 Impact factor: 4.123
Authors: Willem G van Ginkel; Hannah E van Reemst; Nienke S Kienstra; Anne Daly; Iris L Rodenburg; Anita MacDonald; Johannes G M Burgerhof; Pim de Blaauw; Jennifer van de Krogt; Saikat Santra; M Rebecca Heiner-Fokkema; Francjan J van Spronsen Journal: Nutrients Date: 2019-11-18 Impact factor: 5.717